beta

AMPH

Amphastar Pharmaceuticals Inc.

Amph

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

11-08-2018 after market close 08-08-2018 after market close 05-09-2018 after market close 03-12-2018 after market close 11-08-2017 after market close 08-09-2017 after market close 05-08-2017 after market close
Actual EPS 0.12 0.03 -0.05 0.1 0.07 0.11 0.03
Consensus EPS 0.12 0.08 0.09 -0.04 0.02 0.06 0.06
Estimated EPS 0.12 0.08 0.09 -0.04 0.02 0.06 0.06
Number of Estimates 4 4 4 4 4 4 4
EPS Surprise -$0.05 -$0.14 $0.14 $0.05 $0.05 -$0.03

Stats

Summary

Amphastar Pharmaceuticals Inc is a specialty pharmaceutical company engaged in developing, manufacturing, marketing and selling generic and proprietary injectable & inhalation products. Its products are used in hospitals or urgent care clinical settings.

Market Cap: 892 Million

Primary Exchange: Nasdaq Global Select

Website: http://www.amphastar.com

Shares Outstanding: 46 Million

Float: 45 Million

Dividend: 0.0 (0.0%)

Beta: 1.503764

Sector: Healthcare

Industry: Drug Manufacturers

Short Interest (Jan 12, 2018): 2.22 Million

Ethical Flags

Animal testing

Longest drawdown: 490 trading days

From: 2016-11-17 To: 2018-11-08

Lowest Point:

60 Minutes to air piece on opioid drugmakers and distributors Sunday

via: SeekingAlpha at 2018-12-14 13:50:08:000

CBS' 60 Minutes will air a segment this Sunday featuring Ohio governor-elect Mike DeWine (formerly the AG) criticizing certain drug companies and distributors over their role in the opioid crisis. According to reporter Bill Whitaker, Mr. DeWine says the evidence, obtained from the confiden… read more...

60 Minutes to air piece on opioid drugmakers and distributors Sunday

via: SeekingAlpha at 2018-12-14 13:50:08:000

CBS' 60 Minutes will air a segment this Sunday featuring Ohio governor-elect Mike DeWine (formerly the AG) criticizing certain drug companies and distributors over their role in the opioid crisis. According to reporter Bill Whitaker, Mr. DeWine says the evidence, obtained from the confiden… read more...

60 Minutes to air piece on opioid drugmakers and distributors Sunday

via: SeekingAlpha at 2018-12-14 13:50:08:000

CBS' 60 Minutes will air a segment this Sunday featuring Ohio governor-elect Mike DeWine (formerly the AG) criticizing certain drug companies and distributors over their role in the opioid crisis. According to reporter Bill Whitaker, Mr. DeWine says the evidence, obtained from the confiden… read more...

60 Minutes to air piece on opioid drugmakers and distributors Sunday

via: SeekingAlpha at 2018-12-14 13:50:08:000

CBS' 60 Minutes will air a segment this Sunday featuring Ohio governor-elect Mike DeWine (formerly the AG) criticizing certain drug companies and distributors over their role in the opioid crisis. According to reporter Bill Whitaker, Mr. DeWine says the evidence, obtained from the confiden… read more...

Generics under pressure on expanded price-fixing investigation

via: SeekingAlpha at 2018-12-10 12:53:46:000

The broad market's bearishness notwithstanding, generic drug makers are predominantly in the red on the news that the investigation into alleged price-fixing by state AGs now totals 47. More news on: Aceto Corporation, Aclaris Therapeutics, Akorn, Inc., Healthcare stocks news, Stocks on th… read more...

Generics under pressure on expanded price-fixing investigation

via: SeekingAlpha at 2018-12-10 12:53:46:000

The broad market's bearishness notwithstanding, generic drug makers are predominantly in the red on the news that the investigation into alleged price-fixing by state AGs now totals 47. More news on: Aceto Corporation, Aclaris Therapeutics, Akorn, Inc., Healthcare stocks news, Stocks on th… read more...

Apple suppliers, chips drop on Cirrus cut

via: SeekingAlpha at 2018-12-04 11:15:29:000

Apple suppliers and chips are down after this morning's analyst downgrade and yesterday's Cirrus Logic guidance cut on the weak smartphone market. More news on: Lumentum Holdings Inc., II-VI Incorporated, STMicroelectronics NV, Tech stocks news, Stocks on the move, , Top stock market news,… read more...

Apple suppliers, chips drop on Cirrus cut

via: SeekingAlpha at 2018-12-04 11:15:29:000

Apple suppliers and chips are down after this morning's analyst downgrade and yesterday's Cirrus Logic guidance cut on the weak smartphone market. More news on: Lumentum Holdings Inc., II-VI Incorporated, STMicroelectronics NV, Tech stocks news, Stocks on the move, , Top stock market news,… read more...

Apple suppliers, chips drop on Cirrus cut

via: SeekingAlpha at 2018-12-04 11:15:29:000

Apple suppliers and chips are down after this morning's analyst downgrade and yesterday's Cirrus Logic guidance cut on the weak smartphone market. More news on: Lumentum Holdings Inc., II-VI Incorporated, STMicroelectronics NV, Tech stocks news, Stocks on the move, , Top stock market news,… read more...

Apple suppliers, chips drop on Cirrus cut

via: SeekingAlpha at 2018-12-04 11:15:29:000

Apple suppliers and chips are down after this morning's analyst downgrade and yesterday's Cirrus Logic guidance cut on the weak smartphone market. More news on: Lumentum Holdings Inc., II-VI Incorporated, STMicroelectronics NV, Tech stocks news, Stocks on the move, , Top stock market news,… read more...

Amphastar (AMPH) Presents At Piper Jaffray 30th Annual Healthcare Conference - Slideshow

via: SeekingAlpha at 2018-11-29 14:10:41:000

The following slide deck was published by Amphastar in conjunction with this Read more … read more...

Amphastar (AMPH) Presents At Piper Jaffray 30th Annual Healthcare Conference - Slideshow

via: SeekingAlpha at 2018-11-29 14:10:41:000

The following slide deck was published by Amphastar in conjunction with this Read more … read more...

Amphastar (AMPH) Presents At Piper Jaffray 30th Annual Healthcare Conference - Slideshow

via: SeekingAlpha at 2018-11-29 14:10:41:000

The following slide deck was published by Amphastar in conjunction with this Read more … read more...

Amphastar: It's Primatene Time

via: SeekingAlpha at 2018-11-21 13:15:43:000

Available Soon in Stores Near You On August 8th, 2018, I shared an article with my SA readers where I first addressed my due diligence process and why Amphastar ( AMPH ) met the criteria I looked for in making my investment decisions. At the time of this article, Amphastar was trading fo… read more...

Amphastar: It's Primatene Time

via: SeekingAlpha at 2018-11-21 13:15:43:000

Available Soon in Stores Near You On August 8th, 2018, I shared an article with my SA readers where I first addressed my due diligence process and why Amphastar ( AMPH ) met the criteria I looked for in making my investment decisions. At the time of this article, Amphastar was trading fo… read more...

Amphastar: It's Primatene Time

via: SeekingAlpha at 2018-11-21 13:15:43:000

Available Soon in Stores Near You On August 8th, 2018, I shared an article with my SA readers where I first addressed my due diligence process and why Amphastar ( AMPH ) met the criteria I looked for in making my investment decisions. At the time of this article, Amphastar was trading fo… read more...

Amphastar: It's Primatene Time

via: SeekingAlpha at 2018-11-21 13:15:43:000

Available Soon in Stores Near You On August 8th, 2018, I shared an article with my SA readers where I first addressed my due diligence process and why Amphastar ( AMPH ) met the criteria I looked for in making my investment decisions. At the time of this article, Amphastar was trading fo… read more...

Apple suppliers recover despite Qorvo guide cut

via: SeekingAlpha at 2018-11-13 12:08:58:000

Apple suppliers largely recover from yesterdays plunge after Lumentum cut its guidance on weaker orders from a large customer. The recovery comes even after supplier Qorvo cut its own guidance and Foxconn missed profit estimates in its earnings report. More news on: Lumentum Holdi… read more...

Apple suppliers recover despite Qorvo guide cut

via: SeekingAlpha at 2018-11-13 12:08:58:000

Apple suppliers largely recover from yesterdays plunge after Lumentum cut its guidance on weaker orders from a large customer. The recovery comes even after supplier Qorvo cut its own guidance and Foxconn missed profit estimates in its earnings report. More news on: Lumentum Holdi… read more...

Apple suppliers recover despite Qorvo guide cut

via: SeekingAlpha at 2018-11-13 12:08:58:000

Apple suppliers largely recover from yesterdays plunge after Lumentum cut its guidance on weaker orders from a large customer. The recovery comes even after supplier Qorvo cut its own guidance and Foxconn missed profit estimates in its earnings report. More news on: Lumentum Holdi… read more...

Apple suppliers drop on Lumentum guide, iPhone target cuts

via: SeekingAlpha at 2018-11-12 10:49:31:000

Apples iPhone suppliers are dropping after peer Lumentum lowered guidance on cut shipments and analysts warned of soft iPhone sales. More news on: Cirrus Logic, Inc., Finisar Corporation, II-VI Incorporated, Tech stocks news, , Stocks on the move, Read more … read more...

Amphastar (AMPH) Q3 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-11-08 21:43:17:000

Amphastar (AMPH) Q3 2018 Results Earnings Conference Call November 8, 2018, 05:00 PM ET Executives Jason Shandell - President Bill Peters - CFO Analysts David Amsellem - Piper Jaffray Elliot Wilbur - Raymond James David Maris - Wells Fargo David Steinberg - Jeffries G… read more...

Amphastar (AMPH) Q3 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-11-08 21:43:17:000

Amphastar (AMPH) Q3 2018 Results Earnings Conference Call November 8, 2018, 05:00 PM ET Executives Jason Shandell - President Bill Peters - CFO Analysts David Amsellem - Piper Jaffray Elliot Wilbur - Raymond James David Maris - Wells Fargo David Steinberg - Jeffries G… read more...

Amphastar (AMPH) Q3 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-11-08 21:43:17:000

Amphastar (AMPH) Q3 2018 Results Earnings Conference Call November 8, 2018, 05:00 PM ET Executives Jason Shandell - President Bill Peters - CFO Analysts David Amsellem - Piper Jaffray Elliot Wilbur - Raymond James David Maris - Wells Fargo David Steinberg - Jeffries G… read more...

Amphastar beats by $0.01, beats on revenue

via: SeekingAlpha at 2018-11-08 16:15:04:000

Amphastar (NASDAQ: AMPH ): Q3 Non-GAAP EPS of $0.12 beats by $0.01 ; GAAP EPS of $0.05 misses by $0.08 . More news on: Amphastar, Earnings news and commentary, Healthcare stocks news, Read more … read more...

Notable earnings after Thursday's close

via: SeekingAlpha at 2018-11-07 17:35:08:000

AGO , AL , ALTR , AMBR , AMC , AMPH , AQN , ARRS , ASRT , ATVI , BOJA , BPI , BRS , BW , CBPX , COLD , COLL , CTL , CYRX , DBX , DIS , DOX , ECOM , EGAN , EPAY , ERI , FGEN , FOE , FSCT , FSM , FTCH , GMED , HDP , HTZ , ICUI , JAG , JJSF , LGF.A , LOPE… read more...

Trump signs STOP Act aimed at opioid crisis

via: SeekingAlpha at 2018-10-24 09:24:12:000

President Trump signs the STOP Act today, sweeping bipartisan legislation aimed at addressing the opioid crisis. More news on: Endo International plc, Mallinckrodt PLC, INDIVIOR PLC ADR, Healthcare stocks news, Read more … read more...

Trump signs STOP Act aimed at opioid crisis

via: SeekingAlpha at 2018-10-24 09:24:12:000

President Trump signs the STOP Act today, sweeping bipartisan legislation aimed at addressing the opioid crisis. More news on: Endo International plc, Mallinckrodt PLC, INDIVIOR PLC ADR, Healthcare stocks news, Read more … read more...

Trump signs STOP Act aimed at opioid crisis

via: SeekingAlpha at 2018-10-24 09:24:12:000

President Trump signs the STOP Act today, sweeping bipartisan legislation aimed at addressing the opioid crisis. More news on: Endo International plc, Mallinckrodt PLC, INDIVIOR PLC ADR, Healthcare stocks news, Read more … read more...

Generics in the green following proposed favorable guidance from FDA

via: SeekingAlpha at 2018-10-02 14:03:56:000

Most generic drug firms are enjoying an uptick in buying. This morning, FDA Commissioner Scott Gottlieb, M.D., released a statement on preliminary guidance aimed at making the review process for generic drug applications more efficient. More news on: Aceto Corporation, Aclaris Therapeutics… read more...

Generics in the green following proposed favorable guidance from FDA

via: SeekingAlpha at 2018-10-02 14:03:56:000

Most generic drug firms are enjoying an uptick in buying. This morning, FDA Commissioner Scott Gottlieb, M.D., released a statement on preliminary guidance aimed at making the review process for generic drug applications more efficient. More news on: Aceto Corporation, Aclaris Therapeutics… read more...

Generics in the green following proposed favorable guidance from FDA

via: SeekingAlpha at 2018-10-02 14:03:56:000

Most generic drug firms are enjoying an uptick in buying. This morning, FDA Commissioner Scott Gottlieb, M.D., released a statement on preliminary guidance aimed at making the review process for generic drug applications more efficient. More news on: Aceto Corporation, Aclaris Therapeutics… read more...

Senate vote approaches on bill to combat opioid crisis

via: SeekingAlpha at 2018-09-07 12:48:02:000

The Senate will vote next week on the Opioid Crisis Response Act, a lineup of over 70 proposals to fight the opioid crisis following the 50 opioid-related bills that passed the House in June. More news on: Endo International plc, Mallinckrodt PLC, INDIVIOR PLC ADR, Healthcare stocks news… read more...

Senate vote approaches on bill to combat opioid crisis

via: SeekingAlpha at 2018-09-07 12:48:02:000

The Senate will vote next week on the Opioid Crisis Response Act, a lineup of over 70 proposals to fight the opioid crisis following the 50 opioid-related bills that passed the House in June. More news on: Endo International plc, Mallinckrodt PLC, INDIVIOR PLC ADR, Healthcare stocks news… read more...

Senate vote approaches on bill to combat opioid crisis

via: SeekingAlpha at 2018-09-07 12:48:02:000

The Senate will vote next week on the Opioid Crisis Response Act, a lineup of over 70 proposals to fight the opioid crisis following the 50 opioid-related bills that passed the House in June. More news on: Endo International plc, Mallinckrodt PLC, INDIVIOR PLC ADR, Healthcare stocks news… read more...

Senate vote approaches on bill to combat opioid crisis

via: SeekingAlpha at 2018-09-07 12:48:02:000

The Senate will vote next week on the Opioid Crisis Response Act, a lineup of over 70 proposals to fight the opioid crisis following the 50 opioid-related bills that passed the House in June. More news on: Endo International plc, Mallinckrodt PLC, INDIVIOR PLC ADR, Healthcare stocks news… read more...

Senate vote approaches on bill to combat opioid crisis

via: SeekingAlpha at 2018-09-07 12:48:02:000

The Senate will vote next week on the Opioid Crisis Response Act, a lineup of over 70 proposals to fight the opioid crisis following the 50 opioid-related bills that passed the House in June. More news on: Endo International plc, Mallinckrodt PLC, INDIVIOR PLC ADR, Healthcare stocks news… read more...

FDA updates on multifaceted plan to combat opioid crisis

via: SeekingAlpha at 2018-08-29 12:44:25:000

In a statement , FDA Commissioner Scott Gottlieb, M.D. outlines the FDA's many initiatives aimed at addressing the U.S. opioid crisis. Key points: More news on: Endo International plc, Mallinckrodt PLC, INDIVIOR PLC ADR, Healthcare stocks news, Read more … read more...

FDA updates on multifaceted plan to combat opioid crisis

via: SeekingAlpha at 2018-08-29 12:44:25:000

In a statement , FDA Commissioner Scott Gottlieb, M.D. outlines the FDA's many initiatives aimed at addressing the U.S. opioid crisis. Key points: More news on: Endo International plc, Mallinckrodt PLC, INDIVIOR PLC ADR, Healthcare stocks news, Read more … read more...

FDA updates on multifaceted plan to combat opioid crisis

via: SeekingAlpha at 2018-08-29 12:44:25:000

In a statement , FDA Commissioner Scott Gottlieb, M.D. outlines the FDA's many initiatives aimed at addressing the U.S. opioid crisis. Key points: More news on: Endo International plc, Mallinckrodt PLC, INDIVIOR PLC ADR, Healthcare stocks news, Read more … read more...

FDA clamps down on opioid-peddling websites

via: SeekingAlpha at 2018-08-28 10:57:45:000

The FDA has sent Warning Letters to four additional online networks operating a total of 21 websites for illegally promoting opioids to Americans. The action follows the issuance of 13 Warning Letters to more than 70 websites over the summer. More news on: Endo International plc, Mallinc… read more...

FDA awards contract to develop guidelines for opioid prescribing

via: SeekingAlpha at 2018-08-22 11:16:23:000

The FDA has awarded a contract to the National Academies of Sciences, Engineering and Medicine to help advance the development of evidence-based guidelines to help physicians prescribe opioid pain meds in a more appropriate way. More news on: Endo International plc, Mallinckrodt PLC, IND… read more...

FDA awards contract to develop guidelines for opioid prescribing

via: SeekingAlpha at 2018-08-22 11:16:23:000

The FDA has awarded a contract to the National Academies of Sciences, Engineering and Medicine to help advance the development of evidence-based guidelines to help physicians prescribe opioid pain meds in a more appropriate way. More news on: Endo International plc, Mallinckrodt PLC, IND… read more...

FDA awards contract to develop guidelines for opioid prescribing

via: SeekingAlpha at 2018-08-22 11:16:23:000

The FDA has awarded a contract to the National Academies of Sciences, Engineering and Medicine to help advance the development of evidence-based guidelines to help physicians prescribe opioid pain meds in a more appropriate way. More news on: Endo International plc, Mallinckrodt PLC, IND… read more...

White House proposing cuts in opioid production

via: SeekingAlpha at 2018-08-16 15:24:55:000

Aimed at fighting the U.S. opioid crisis, the Trump administration is proposing production cuts in the most-abused compounds, oxycodone, hydrocodone, oxymorphone, hydromorphone, morphine and fentanyl, by 10% next year. More news on: Endo International plc, Mallinckrodt PLC, Johnson &… read more...

White House proposing cuts in opioid production

via: SeekingAlpha at 2018-08-16 15:24:55:000

Aimed at fighting the U.S. opioid crisis, the Trump administration is proposing production cuts in the most-abused compounds, oxycodone, hydrocodone, oxymorphone, hydromorphone, morphine and fentanyl, by 10% next year. More news on: Endo International plc, Mallinckrodt PLC, Johnson &… read more...

White House proposing cuts in opioid production

via: SeekingAlpha at 2018-08-16 15:24:55:000

Aimed at fighting the U.S. opioid crisis, the Trump administration is proposing production cuts in the most-abused compounds, oxycodone, hydrocodone, oxymorphone, hydromorphone, morphine and fentanyl, by 10% next year. More news on: Endo International plc, Mallinckrodt PLC, Johnson &… read more...

Amphastar (AMPH) Q2 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-08-11 15:11:07:000

Amphastar. (AMPH) Q2 2018 Results Earnings Conference Call August 8, 2018, 05:30 PM ET Executives Jason Shandell - President Bill Peters - CFO Analysts Lucas Lee - Raymond James David Maris - Wells Fargo David Amsellem - Piper Jaffray Gary Nachman - BMO Capital Markets … read more...

Amphastar (AMPH) Q2 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-08-11 15:11:07:000

Amphastar. (AMPH) Q2 2018 Results Earnings Conference Call August 8, 2018, 05:30 PM ET Executives Jason Shandell - President Bill Peters - CFO Analysts Lucas Lee - Raymond James David Maris - Wells Fargo David Amsellem - Piper Jaffray Gary Nachman - BMO Capital Markets … read more...

Amphastar (AMPH) Q2 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-08-11 15:11:07:000

Amphastar. (AMPH) Q2 2018 Results Earnings Conference Call August 8, 2018, 05:30 PM ET Executives Jason Shandell - President Bill Peters - CFO Analysts Lucas Lee - Raymond James David Maris - Wells Fargo David Amsellem - Piper Jaffray Gary Nachman - BMO Capital Markets … read more...

Amphastar (AMPH) Q2 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-08-11 15:11:07:000

Amphastar. (AMPH) Q2 2018 Results Earnings Conference Call August 8, 2018, 05:30 PM ET Executives Jason Shandell - President Bill Peters - CFO Analysts Lucas Lee - Raymond James David Maris - Wells Fargo David Amsellem - Piper Jaffray Gary Nachman - BMO Capital Markets … read more...

Amphastar: A Rising Star In The China Pharmaceutical Markets

via: SeekingAlpha at 2018-08-08 21:38:10:000

Amphastar( AMPH ) is a specialty pharmaceutical with their headquarters located in Rancho Cucamonga, California. Worldwide they have more than 1,600 employees. Their product line is directed toward developing, marketing and selling generic and injectable, inhaled and intranasal generic product… read more...

Amphastar: A Rising Star In The China Pharmaceutical Markets

via: SeekingAlpha at 2018-08-08 21:38:10:000

Amphastar( AMPH ) is a specialty pharmaceutical with their headquarters located in Rancho Cucamonga, California. Worldwide they have more than 1,600 employees. Their product line is directed toward developing, marketing and selling generic and injectable, inhaled and intranasal generic product… read more...

Amphastar misses by $0.04, beats on revenue

via: SeekingAlpha at 2018-08-08 16:24:12:000

Amphastar (NASDAQ: AMPH ): Q2 EPS of $0.03 misses by $0.04 . More news on: Amphastar, Earnings news and commentary, Healthcare stocks news, Read more … read more...

Mylan's trimmed guidance may pressure generic drug makers

via: SeekingAlpha at 2018-08-08 09:07:22:000

Mylan (NASDAQ: MYL ) is under modest pressure premarket, down 5% on average volume, after cutting its 2018 guidance due to continued challenges in the U.S. market, a move that could stoke selling in the generics space. More news on: Mylan Inc, Teva Pharmaceutical Industries Lim… read more...

Notable earnings after Wednesday's close

via: SeekingAlpha at 2018-08-07 17:35:37:000

ACAD , ACTG , ADT , AINV , AMBC , AMPH , ANGI , AOSL , APEI , ATO , AVT , AYX , AZPN , BKNG , BREW , BV , CISN , COLL , CPA , CTL , CVNA , CXW , DNB , DOOR , ECPG , ELF , ENS , EQIX , ETE , ETP , EVRG , FANG , FG , FLO , FLS , FNV , FOXA , FSM , GBDC ,… read more...

Amphastar announces expansion of Amphastar Nanjing Pharmaceuticals Inc.

via: SeekingAlpha at 2018-07-09 08:45:28:000

Amphastar Pharmaceuticals (NASDAQ: AMPH ) announced business expansion plans for its subsidiary, Amphastar Nanjing Pharmaceuticals Inc., to manufacture finished pharmaceutical products for distribution in China and in other markets globally. More news on: Amphastar, Healthcare stocks new… read more...

Amphastar announces expansion of Amphastar Nanjing Pharmaceuticals Inc.

via: SeekingAlpha at 2018-07-09 08:45:28:000

Amphastar Pharmaceuticals (NASDAQ: AMPH ) announced business expansion plans for its subsidiary, Amphastar Nanjing Pharmaceuticals Inc., to manufacture finished pharmaceutical products for distribution in China and in other markets globally. More news on: Amphastar, Healthcare stocks new… read more...

Amphastar announces expansion of Amphastar Nanjing Pharmaceuticals Inc.

via: SeekingAlpha at 2018-07-09 08:45:28:000

Amphastar Pharmaceuticals (NASDAQ: AMPH ) announced business expansion plans for its subsidiary, Amphastar Nanjing Pharmaceuticals Inc., to manufacture finished pharmaceutical products for distribution in China and in other markets globally. More news on: Amphastar, Healthcare stocks new… read more...

Your Daily Pharma Scoop: Anika Fails Trial, Kala's Upcoming Catalyst, Sarepta Surges

via: SeekingAlpha at 2018-06-21 08:00:00:000

Analysis Focus: ANIK Anika Therapeutics ( ANIK ) announced failure of its candidate CINGAL to achieve primary endpoint in a Phase 3 clinical trial in knee osteoarthritis (OA). CINGAL could not succeed in showing a statistically significant reduction in knee pain. CINGAL is a combin… read more...

Your Daily Pharma Scoop: Anika Fails Trial, Kala's Upcoming Catalyst, Sarepta Surges

via: SeekingAlpha at 2018-06-21 08:00:00:000

Analysis Focus: ANIK Anika Therapeutics ( ANIK ) announced failure of its candidate CINGAL to achieve primary endpoint in a Phase 3 clinical trial in knee osteoarthritis (OA). CINGAL could not succeed in showing a statistically significant reduction in knee pain. CINGAL is a combin… read more...

FDA approves Amphastar's ANDA for Isoproterenol Hydrochloride Injection, USP

via: SeekingAlpha at 2018-06-19 07:51:03:000

FDA approves Amphastar Pharmaceuticals' (NASDAQ: AMPH ) abbreviated new drug application (ANDA) for Isoproterenol Hydrochloride Injection, USP 0.2mg/mL, 1mL and 0.2mg/mL, 5mL single dose vial. More news on: Amphastar, Healthcare stocks news, Read more … read more...

FDA approves Amphastar's ANDA for Isoproterenol Hydrochloride Injection, USP

via: SeekingAlpha at 2018-06-19 07:51:03:000

FDA approves Amphastar Pharmaceuticals' (NASDAQ: AMPH ) abbreviated new drug application (ANDA) for Isoproterenol Hydrochloride Injection, USP 0.2mg/mL, 1mL and 0.2mg/mL, 5mL single dose vial. More news on: Amphastar, Healthcare stocks news, Read more … read more...

Daily Insider Ratings Round Up 5/17/18

via: SeekingAlpha at 2018-05-18 17:13:07:000

InsiderInsights' Daily Round Up articles rate the "significance" of the top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the significance of an insider transaction, however, and there are many more "Signifi… read more...

FDA OKs first non-opioid treatment for opioid withdrawal

via: SeekingAlpha at 2018-05-16 16:44:42:000

The FDA approves privately held US WorldMeds LLC's Lucemyra (lofexidine hydrochloride) for the management of opioid withdrawal symptoms in adults who abruptly discontinue opioids. More news on: Endo International plc, Allergan plc, Johnson & Johnson, Healthcare stocks news, Read … read more...

FDA OKs first non-opioid treatment for opioid withdrawal

via: SeekingAlpha at 2018-05-16 16:44:42:000

The FDA approves privately held US WorldMeds LLC's Lucemyra (lofexidine hydrochloride) for the management of opioid withdrawal symptoms in adults who abruptly discontinue opioids. More news on: Endo International plc, Allergan plc, Johnson & Johnson, Healthcare stocks news, Read … read more...

Amphastar Pharmaceuticals' (AMPH) Q1 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-05-14 14:20:04:000

Amphastar Pharmaceuticals, Inc. (AMPH) Q1 2018 Earnings Conference Call May 09, 2018 05:00 PM ET Executives Jason Shandell - President Bill Peters - CFO Analysts David Amsellem - Piper Jaffray David Maris - Wells Fargo Gary Nachman - BMO Capital Markets David Steinberg … read more...

Amphastar Pharmaceuticals' (AMPH) Q1 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-05-14 14:20:04:000

Amphastar Pharmaceuticals, Inc. (AMPH) Q1 2018 Earnings Conference Call May 09, 2018 05:00 PM ET Executives Jason Shandell - President Bill Peters - CFO Analysts David Amsellem - Piper Jaffray David Maris - Wells Fargo Gary Nachman - BMO Capital Markets David Steinberg … read more...

Amphastar misses by $0.13, misses on revenue

via: SeekingAlpha at 2018-05-09 16:22:01:000

Amphastar (NASDAQ: AMPH ): Q1 EPS of -$0.05 misses by $0.13 . More news on: Amphastar, Earnings news and commentary, Healthcare stocks news, Read more … read more...

Amphastar misses by $0.13, misses on revenue

via: SeekingAlpha at 2018-05-09 16:22:01:000

Amphastar (NASDAQ: AMPH ): Q1 EPS of -$0.05 misses by $0.13 . More news on: Amphastar, Earnings news and commentary, Healthcare stocks news, Read more … read more...

Notable earnings after Wednesday's close

via: SeekingAlpha at 2018-05-08 17:35:11:000

AG , ALB , AMPH , ANGI , ATUS , AYX , BLDR , BOLD , BREW , COLL , CPA , CTL , CVNA , DAR , DNB , EEP , ELF , ENV , ETE , ETP , EVH , FG , FGEN , FNGN , FNV , FOXA , FSM , FTI , FTK , GDOT , GKOS , HLI , IAC , ICUI , INFN , MBI , MELI , MRAM , MTRX , N… read more...

Notable earnings after Wednesday's close

via: SeekingAlpha at 2018-05-08 17:35:11:000

AG , ALB , AMPH , ANGI , ATUS , AYX , BLDR , BOLD , BREW , COLL , CPA , CTL , CVNA , DAR , DNB , EEP , ELF , ENV , ETE , ETP , EVH , FG , FGEN , FNGN , FNV , FOXA , FSM , FTI , FTK , GDOT , GKOS , HLI , IAC , ICUI , INFN , MBI , MELI , MRAM , MTRX , N… read more...

Opioid prescriptions dropped 12% in 2017

via: SeekingAlpha at 2018-04-26 03:18:20:000

Opioid prescriptions dropped 12% in 2017, according to a report from the IQVIA Institute for Human Data Science. More news on: Johnson & Johnson, Endo International plc, Teva Pharmaceutical Industries Limited, Healthcare stocks news, Read more … read more...

Opioid prescriptions dropped 12% in 2017

via: SeekingAlpha at 2018-04-26 03:18:20:000

Opioid prescriptions dropped 12% in 2017, according to a report from the IQVIA Institute for Human Data Science. More news on: Johnson & Johnson, Endo International plc, Teva Pharmaceutical Industries Limited, Healthcare stocks news, Read more … read more...

U.S. opioid prescriptions down 12% last year, largest drop in 25 years

via: SeekingAlpha at 2018-04-19 11:25:01:000

According to IQVIA ( IQV -0.8% ), U.S. opioid prescriptions declined 12% in 2017, the largest annual drop in 25 years as doctors respond to the opioid crisis. More news on: IQVIA Holdings, Inc., Insys Therapeutics, Inc., Johnson & Johnson, Healthcare stocks news, News on ETFs, … read more...

U.S. opioid prescriptions down 12% last year, largest drop in 25 years

via: SeekingAlpha at 2018-04-19 11:25:01:000

According to IQVIA ( IQV -0.8% ), U.S. opioid prescriptions declined 12% in 2017, the largest annual drop in 25 years as doctors respond to the opioid crisis. More news on: IQVIA Holdings, Inc., Insys Therapeutics, Inc., Johnson & Johnson, Healthcare stocks news, News on ETFs, … read more...

DEA aiming to collar production of opioids

via: SeekingAlpha at 2018-04-17 15:35:03:000

The U.S. Drug Enforcement Administration (DEA) has unveiled plans to restrict the amount of opioids made by drug firms if it believes the medications are being diverted for illicit use. The proposed new rules were announced today in a speech by Attorney General Jeff Sessions. More news o… read more...

DEA aiming to collar production of opioids

via: SeekingAlpha at 2018-04-17 15:35:03:000

The U.S. Drug Enforcement Administration (DEA) has unveiled plans to restrict the amount of opioids made by drug firms if it believes the medications are being diverted for illicit use. The proposed new rules were announced today in a speech by Attorney General Jeff Sessions. More news o… read more...

Sen. Sanders introduces bill to fine opioid makers for marketing practices

via: SeekingAlpha at 2018-04-17 12:03:04:000

Reuters reports that U.S. Senator Bernie Sanders (I-VT) plans to introduce a bill today that would fine makers of opioid medications for deceptive marketing and implement harsh penalties for those found responsible for contributing to the drug epidemic. More news on: Insys Therapeutics, … read more...

Sen. Sanders introduces bill to fine opioid makers for marketing practices

via: SeekingAlpha at 2018-04-17 12:03:04:000

Reuters reports that U.S. Senator Bernie Sanders (I-VT) plans to introduce a bill today that would fine makers of opioid medications for deceptive marketing and implement harsh penalties for those found responsible for contributing to the drug epidemic. More news on: Insys Therapeutics, … read more...

Will Opiant Pharma Solve The Biggest Crisis That The FDA Is Currently Facing?

via: SeekingAlpha at 2018-04-11 05:49:01:000

In an interview with CNN on Thursday, Food and Drug Administration Commissioner Dr. Scott Gottlieb said that the opioid epidemic is still the biggest challenge that the FDA is currently facing. Last month, Trump administration announced a new plan to combat the epidemic by enactin… read more...

Will Opiant Pharma Solve The Biggest Crisis That The FDA Is Currently Facing?

via: SeekingAlpha at 2018-04-11 05:49:01:000

In an interview with CNN on Thursday, Food and Drug Administration Commissioner Dr. Scott Gottlieb said that the opioid epidemic is still the biggest challenge that the FDA is currently facing. Last month, Trump administration announced a new plan to combat the epidemic by enactin… read more...

Amphastar Pharmaceuticals (AMPH) Presents At Needham and Company 17th Annual Healthcare Conference - Slideshow

via: SeekingAlpha at 2018-03-29 14:04:10:000

The following slide deck was published by Amphastar in conjunction with this Read more … read more...

MannKind Scripts Recover As Q1 Nears Completion

via: SeekingAlpha at 2018-03-24 06:06:29:000

MannKind (MNKD) investors got a bit of relief this past week after seeing scripts in the previous week dip below 400. Afrezza scripts came in at just over 450 for the week ending March 16th. This brings the total for the quarter to just over 4,600. With two weeks of sales to go in Q1, it looks… read more...

Wall Street Breakfast: Infrastructure Details Coming Today

via: SeekingAlpha at 2018-02-12 07:07:40:000

The White House will roll out a long-awaited infrastructure plan today, which already faces hurdles in Congress because it doesn't offer as much new federal funding as Democrats want, or directly address how to pay for the effort. President Trump will propose spending $200B over 10… read more...

Wall Street Breakfast: Infrastructure Details Coming Today

via: SeekingAlpha at 2018-02-12 07:07:40:000

The White House will roll out a long-awaited infrastructure plan today, which already faces hurdles in Congress because it doesn't offer as much new federal funding as Democrats want, or directly address how to pay for the effort. President Trump will propose spending $200B over 10… read more...

OxyContin maker stops promoting opioids

via: SeekingAlpha at 2018-02-11 07:37:10:000

OxyContin maker Purdue Pharma is stopping to promote the drug and other opioids to doctors amid a series of state and municipal lawsuits that blame the company for contributing to the opioid epidemic. More news on: Johnson & Johnson, Endo International plc, Teva Pharmaceutical Indust… read more...

OxyContin maker stops promoting opioids

via: SeekingAlpha at 2018-02-11 07:37:10:000

OxyContin maker Purdue Pharma is stopping to promote the drug and other opioids to doctors amid a series of state and municipal lawsuits that blame the company for contributing to the opioid epidemic. More news on: Johnson & Johnson, Endo International plc, Teva Pharmaceutical Indust… read more...

OxyContin maker stops promoting opioids

via: SeekingAlpha at 2018-02-11 07:37:10:000

OxyContin maker Purdue Pharma is stopping to promote the drug and other opioids to doctors amid a series of state and municipal lawsuits that blame the company for contributing to the opioid epidemic. More news on: Johnson & Johnson, Endo International plc, Teva Pharmaceutical Indust… read more...

U.S. Justice Department may seek damages from generic drugmakers for price-fixing

via: SeekingAlpha at 2018-01-19 13:16:00:000

Some generic drug firms are under modest pressure in apparent response to a speech delivered by U.S. Department of Justice antitrust division chief Makan Delrahim earlier today at George Mason University's law school. He said the DOJ may sue generic drug companies to recover damages over all… read more...

Wall Street Breakfast: Investors Calm As Government Shutdown Looms

via: SeekingAlpha at 2018-01-19 07:01:29:000

Markets appear to be shrugging off the potential for a government shutdown as traders are reminded that nearly $6.9T has been added to the U.S. stock market cap over the last year (President Trump will celebrate his inauguration anniversary tomorrow). Though House Republicans have v… read more...

Generic firms under pressure on possible hospital drug-making venture

via: SeekingAlpha at 2018-01-18 10:06:04:000

Generic drug makers are under pressure in early trading on the heels of a New York Times article about hospital groups' plans to establish a non-profit drug company aimed at supplying certain generic drugs at affordable prices. More news on: Amphastar, ANI Pharmaceuticals, Inc., Aclaris Th… read more...

Hospital groups planning to enter generic drugs business

via: SeekingAlpha at 2018-01-18 08:21:15:000

The NYT reports that some U.S. hospital systems are planning to enter the generic drugs business in an effort to preserve the supply of key off-patent medicines at affordable prices. About 300 hospitals, led by Utah-based Intermountain Healthcare, are on board with more to follow. More n… read more...

De-Risking Catalysts Aplenty - Cara Therapeutics

via: SeekingAlpha at 2018-01-17 10:22:32:000

Investment Thesis: Cara Therapeutics ( CARA ) is an established late-clinical stage biotech company focusing on developing novel means for treating pain and pruritus. They currently have 2 Phase III trials (pain and pruritus) underway for their lead candidate delivered via IV, a Phase II tri… read more...

FDA advancing plan to streamline generic drug reviews

via: SeekingAlpha at 2018-01-03 12:54:23:000

The FDA released two documents today aimed at making the generic drug application and review process more efficient, the aim of its Drug Competition Action Plan. More news on: Amphastar, ANI Pharmaceuticals, Inc., Aclaris Therapeutics, Healthcare stocks news, News on ETFs, Read more … read more...

Your Daily Pharma Scoop: Synergy's New CEO, AbbVie Data, TiGenix Changes

via: SeekingAlpha at 2017-12-21 02:41:58:000

Content Analysis of coverage: SGYP Stocks in the news: ABBV, TIG, EGLT Analyst Ratings Insider Sales Insider Purchases Secondary Offerings Earnings Report Earnings Calendar Analysis of top Seeking Alpha coverage: Synergy Pharmaceuticals Today … read more...

Your Daily Pharma Scoop: Aclaris Gets Approval, Egalet Surges, Alnylam Gains As FDA Lifts Clinical Hold

via: SeekingAlpha at 2017-12-17 16:15:23:000

Content Analysis of coverage: ACRS Stocks in the news: EGLT, TSRO Analyst Ratings Insider Sales Insider Purchases Earnings Report Secondary Offerings Earnings Calendar Daily Trade Idea: (for TPT Subscribers only) Subscriber Questions & Answers (for T… read more...

Does Amphastar's Pipeline Warrant Its Valuation?

via: SeekingAlpha at 2017-12-13 13:05:25:000

In early 2017 , I was particularly bearish on shares of specialty generics maker Amphastar ( AMPH ). I thought shares would decline significantly throughout 2017, and it looked my prediction was on-track until the company received a product approval in September and shares gradually drifted t… read more...

Your Daily Pharma Scoop: Gilead's Potential, Celgene CAR-T Candidate, Cellectar Soars

via: SeekingAlpha at 2017-12-07 08:00:00:000

This abridged Daily Scoop is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. Total Pharma Tracker subscribers get the full version with actionable ideas one day ea… read more...

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided for free by IEX